E-LIB Suche - Ergebnisse für: Ström, O.

1

A novel economic framework to assess the cost-effectiveness..:

Söreskog, E. ; Borgström, F. ; Lindberg, I....
Osteoporosis International. 32 (2021) 7 - p. 1301-1311 , 2021

Link: https://doi.org/10.1007/..

2

Cost-effectiveness of romosozumab for the treatment of post..:

Söreskog, E. ; Lindberg, I. ; Kanis, J.A....
Osteoporosis International. 32 (2021) 3 - p. 585-594 , 2021

Link: https://doi.org/10.1007/..

3

Real-world effectiveness of osteoporosis treatment in the o..:

Ström, O. ; Lauppe, R. ; Ljunggren, Ö....
Osteoporosis International. 31 (2020) 8 - p. 1525-1533 , 2020

Link: https://doi.org/10.1007/..

4

Risk of imminent fracture following a previous fracture in ..:

Banefelt, J. ; Åkesson, K.E. ; Spångéus, A....
Osteoporosis International. 30 (2019) 3 - p. 601-609 , 2019

Link: https://doi.org/10.1007/..

5

PUK6 A COST-EFFECTIVENESS MODEL FOR SECONDARY HYPERPARATHYR..:

Lilja, M. ; Lauppe, R. ; Intorcia, M....
Value in Health. 22 (2019) - p. S913-S914 , 2019

Link: https://doi.org/10.1016/..

6

PMS43 - AN ECONOMIC VALUE FRAMEWORK TO ASSESS THE COST EFFE..:

Jonsson, E. ; Borgström, F. ; Ström, O....
Value in Health. 21 (2018) - p. S295 , 2018

Link: https://doi.org/10.1016/..

7

Quality of life for up to 18 months after low-energy hip, v..:

Svedbom, A. ; Borgstöm, F. ; Hernlund, E....
Osteoporosis International. 29 (2017) 3 - p. 557-566 , 2017

Link: https://doi.org/10.1007/..

8

Risk of Major Osteoporotic Fracture (Hip, Vertebral, Radius..:

Jonsson, E ; Ström, O ; Spångéus, A...
Value in Health. 20 (2017) 9 - p. A528 , 2017

Link: https://doi.org/10.1016/..

9

Cost Effectiveness Evaluation of Fracture Liaison Services ..:

Jonsson, E ; Borgström, F ; Ström, O
Value in Health. 19 (2016) 7 - p. A612 , 2016

Link: https://doi.org/10.1016/..

10

The Economic Burden of Hepatitis C In France And Romania:

Ortsäter, G ; Ström, O ; Kautz, A
Value in Health. 19 (2016) 7 - p. A582 , 2016

Link: https://doi.org/10.1016/..

11

Persistence with denosumab and persistence with oral bispho..:

Karlsson, L. ; Lundkvist, J. ; Psachoulia, E...
Osteoporosis International. 26 (2015) 10 - p. 2401-2411 , 2015

Link: https://doi.org/10.1007/..

12

Residual effect after oral bisphosphonate treatment and hea..:

Ström, O. ; Landfeldt, E. ; Garellick, G.
Osteoporosis International. 26 (2014) 1 - p. 315-325 , 2014

Link: https://doi.org/10.1007/..

13

Systematic Review and Meta-Analysis of Persistence With Den..:

Jonsson, E. ; Cheng, L.I. ; Ström, O...
Value in Health. 17 (2014) 7 - p. A383-A384 , 2014

Link: https://doi.org/10.1016/..

14

The International Costs and Utilities Related to Osteoporot..:

Borgström, F. ; Lekander, I. ; Ivergård, M....
Osteoporosis International. 24 (2013) 3 - p. 811-823 , 2013

Link: https://doi.org/10.1007/..

15

Treatment Persistence in Swedish Women Initiating Denosumab..:

Karlsson, L. ; Lundkvist, J. ; Intorcia, M...
Value in Health. 16 (2013) 7 - p. A567 , 2013

Link: https://doi.org/10.1016/..